Log In Request a Trial

Virtual Event: July 15th, 11:00 AM EDT

Proposed Breakups of Live Nation/Ticketmaster with Tommy Dorfman

Join us for a conversation on Live Nation’s alleged monopoly, what the company’s 2026 jury trial could mean for the future of live music, & more.

RSVP

Capitol Forum Exclusive Interview

EU Competition Chief says Bloc ‘Won’t Compromise Sovereignty’ in Talks with U.S., Criticizes American Big Tech Crackdown

Read More

Discover the Benefits of a Subscription

Our content provides subscribers with unique insight and breaking news regarding the most complex mergers and regulatory situations around the world.

Inquire

The Capitol Forum Advantage

Our work combines cutting edge breaking news with in-depth analysis to better inform readers how policy and regulation affects market competition.

Learn More

The Capitol Forum Community

Our editorial team reconstructs the policy process to yield market insight for a community of subscribers including government regulators, lawyers, investors, and non-profits.

Learn More

FEATURED ARTICLES

View all

The Trade Desk: Adtech Company Reports Low Opt-Out Numbers Despite Developing Unique Identifier Tied to 245 Million Individuals

Last year only nine Californians asked The Trade Desk (TTD) to delete personal...

Jul 10, 2025

ADNOC/Covestro: Deal Headed for In-Depth EU Subsidy Probe, Sources Say

ADNOC’s €14.7 billion planned acquisition of chemicals producer Covestro...

Jul 07, 2025

T-Mobile/UScellular: Team Telecom’s Deference Gives DOJ, FCC Flexibility to Penalize Buyer If It Violates Agreement

When the interagency panel known as Team Telecom declined last month to...

Jul 03, 2025

RECENT PODCASTS

View all

Promoting AI Innovation Through Competition

Listen

We speak with Jack Corrigan, Senior Research Analyst at the Center for Security...

Jun 29, 2025

Who’s Really Shaping RFK Jr.’s Health Agenda? Inside the Maha Influencers

Listen

Executive Editor Teddy Downey is joined by Jeremy Furchtgott and Riley Kruse of...

Jun 20, 2025

ABOUT THE CAPITOL FORUM

We are an independent investigative media organization providing our subscribers with breaking news and in-depth analysis on regulatory developments and their impact on markets. Our experienced journalists dive into some of the most complex regulatory issues in the United States, Europe, and China to uncover the key global regulatory issues companies face.


COVERAGE

TESTIMONIALS

Barry Nigro - Partner and Antitrust Chair, Fried Frank

"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."

Katrina Robson - Partner, Willkie Farr & Gallagher

"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."

Mark Ostrau - Partner, Fenwick & West

"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."

Kevin Hahm - Partner, Hunton Andrews Kurth

"I rely on Capitol Forum to get insight and analysis that’s often unavailable from other sources. Their coverage of FTC and DOJ matters is top-notch."

Barry Lynnn - Executive Director, Open Markets Institute

“The Capitol Forum is the only team covering this incredibly important beat. Better yet, their work is deeply intelligent, influential, and almost always right.”

Karl A. Racine - Former D.C. Attorney General

“I appreciate the helpful work done by The Capitol Forum. It’s one of the sources I turn to for information about what activity is out there not only in the antitrust space, but also in the consumer protection world.”

Bert Foer - Former President, American Antitrust Institute

“The Capitol Forum provides an always interesting and sometimes surprising look under the hood about pending antitrust activities.”

Melissa H. Maxman - Partner, Cohen & Gresser

“I have become an avid reader of The Capitol Forum because it provides timely in-depth news and analysis of the myriad legal, business, legislative and political factors affecting business developments. I always come away with fresh perspectives that help me advise my clients about current issues.”

David Witkin - CEO, Beryl Capital Management

“The Capitol Forum has been an indispensable resource for me in analyzing regulatory risk affecting companies in my portfolio or watch list.”

Allen Grunes - Shareholder, Brownstein Hyatt Farber Schreck

“The Capitol Forum consistently provides timely and sophisticated news and analysis of important M & A transactions. It’s the real deal!”

Ted Boettner - Senior Researcher, Ohio River Valley Institute

"Unlike most media outlets, The Capitol Forum digs deep into incredibly complex issues of great importance, providing timely and relevant analysis that you can use to inform your work."

RECENT ARTICLES | EDITOR'S PICKS

View all

RESOURCES

View all
Thank you for subscribing to our newsletter

SPECIAL REPORTS

View all

SPECIAL REPORT: Xponential Fitness Case Study

As the company’s stock soared, Xponential routinely told investors that it had never had a franchised studio close – a metric it used to signal the strength of its systems and the growth potential of its brands. But many franchisees had a different story to tell.

Jan 29, 2025 Read Now >

SPECIAL REPORT: Coordination Out Loud

Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”

Sep 07, 2023 Read Now >

SPECIAL REPORT: Johnson & Johnson’s Remicade

Get an inside view of the biologics market, where rebate schemes appear to drive market share. You’ll learn how a complex system supports sluggish biosimilar uptake and other types of anticompetitive conduct. 

Sep 05, 2023 Read Now >

SPECIAL REPORT: Exclusive Drug Dealing

The Capitol Forum has recently published a special report with an extract of reporting that has been done analyzing price, market share and generic formulary exclusion data to spot anticompetitive conduct.

May 11, 2023 Read Now >